Pneumonia in Rheumatoid Arthritis Patients

Interleukin-22 and Tumor Necrosis Factor Receptor Associated Factor 1 (TRAF1) in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus: Correlation with Disease Activity

Increased Risk of Rheumatoid Arthritis-Related Pulmonary Disease as a Results of Serum Anticitrullinated Protein Antibody Positivity

Asymptomatic Interstitial Lung Disease in Patients with Rheumatoid Arthritis

Evaluation of Drug Effects on IL-17 and TNF levels in Patients with Rheumatoid Arthritis

Respiratory Infections in the Rheumatic Patients: Epidemiology, Pathogenesis, Prophylaxis and Management

Pathogenic Role of Interlukin-23(IL-23) in Rheumatoid Arthritis Patients; its Relation to Disease Activity

Assessment of gut microbiota in rheumatoid arthritis patients

Serum Interleukin-33 in Rheumatoid Arthritis and its Relation to Disease Activity

Effect of Rheumatoid Arthritis Disease Activity on Left Ventricular Function